Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mazdutide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innovent's Mazdutide Shows Superiority Over Dulaglutide In Diabetes Trial
    Innovent's Mazdutide Shows Superiority Over Dulaglutide In Diabetes Trial

    11 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/head-to-head-superiority-over-dulaglutide-innovents-phase-3-clinical-trial-dreams-2-of-mazdutide-in-chinese-patients-with-type-2-diabetes-were-orally-presented-at-easd-2024-302244860.html

    PR NEWSWIRE
    11 Sep 2024
    Share Share
    Innovent Annouces Multiple Clinical Study Results of Mazdutide
    Innovent Annouces Multiple Clinical Study Results of Mazdutide

    01 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-annouces-multiple-clinical-study-results-of-mazdutide-to-be-presented-at-the-easd-2024-302235586.html

    PR NEWSWIRE
    01 Sep 2024
    Share Share
    Innovent bags another phase 3 win in China for next-gen Lilly GLP-1 drug
    Innovent bags another phase 3 win in China for next-gen Lilly GLP-1 drug

    23 Jul 2024

    // BIOSPACE

    https://www.biospace.com/drug-development/innovents-lilly-partnered-type-2-diabetes-drug-aces-phase-iii-in-china-inches-closer-to-approval

    BIOSPACE
    23 Jul 2024
    Share Share
    Innovent Updates Data From Mazdutide GLORY-1 Study And Biomedicine Pipeline
    Innovent Updates Data From Mazdutide GLORY-1 Study And Biomedicine Pipeline

    27 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-provides-interpretation-and-updates-on-clinical-data-from-mazdutide-glory-1-study-and-general-biomedicine-pipeline-302184351.html

    PR NEWSWIRE
    27 Jun 2024
    Share Share
    Innovent To Present Mazdutide Results At ADA Scientific Sessions
    Innovent To Present Mazdutide Results At ADA Scientific Sessions

    12 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-to-present-multiple-clinical-study-results-of-mazdutide-at-the-adas-84th-scientific-sessions-302169495.html

    PR NEWSWIRE
    12 Jun 2024
    Share Share
    Lilly's next-gen obesity drug brings Innovent ph. 3 diabetes win
    Lilly's next-gen obesity drug brings Innovent ph. 3 diabetes win

    09 May 2024

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/lillys-next-gen-obesity-drug-brings-innovent-phase-3-win-diabetes

    James Waldron FIERCE BIOTECH
    09 May 2024
    Share Share